{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:01:19Z","timestamp":1768816879325,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2010-0029220"],"award-info":[{"award-number":["2010-0029220"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2013M3A9D3045879"],"award-info":[{"award-number":["2013M3A9D3045879"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.actbio.2015.09.014","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T07:37:48Z","timestamp":1442043468000},"page":"86-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Enhanced anti-tumor efficacy and safety profile of tumor microenvironment-responsive oncolytic adenovirus nanocomplex by systemic administration"],"prefix":"10.1016","volume":"28","author":[{"given":"Joung-Woo","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasala","family":"Dayananda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Jung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You Han","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chae-Ok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2015.09.014_b0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1517\/14712598.1.3.525","article-title":"Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trials","volume":"1","author":"Kirn","year":"2001","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.actbio.2015.09.014_b0010","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/78638","article-title":"A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer","volume":"6","author":"Khuri","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2015.09.014_b0015","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours","volume":"5","author":"Parato","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2015.09.014_b0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tibtech.2009.01.003","article-title":"Designer adenoviruses for nanomedicine and nanodiagnostics","volume":"27","author":"Singh","year":"2009","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.actbio.2015.09.014_b0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mt.2009.266","article-title":"Current issues and future directions of oncolytic adenoviruses","volume":"18","author":"Yamamoto","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2015.09.014_b0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1566523013349002","article-title":"Cancer gene therapy by adenovirus-mediated gene transfer","volume":"1","author":"Wu","year":"2001","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.actbio.2015.09.014_b0035","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/mt.2010.159","article-title":"Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms","volume":"18","author":"Fridlender","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2015.09.014_b0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.cr.7310032","article-title":"Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors","volume":"16","author":"Xia","year":"2006","journal-title":"Cell Res."},{"key":"10.1016\/j.actbio.2015.09.014_b0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.mt.6300321","article-title":"Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide","volume":"16","author":"Kreppel","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2015.09.014_b0050","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/10430349950018364","article-title":"Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo","volume":"10","author":"Muruve","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2015.09.014_b0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0005-2760(92)90255-T","article-title":"Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol)","volume":"1128","author":"Maruyama","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.actbio.2015.09.014_b0060","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/0022-1317-81-11-2605","article-title":"Blood clearance rates of adenovirus type 5 in mice","volume":"81","author":"Alemany","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.actbio.2015.09.014_b0065","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.addr.2011.12.011","article-title":"Evolution of oncolytic adenovirus for cancer treatment","volume":"64","author":"Choi","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2015.09.014_b0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/bm501116x","article-title":"Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model","volume":"16","author":"Jung","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2015.09.014_b0075","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.addr.2009.12.003","article-title":"HPMA copolymers for masking and retargeting of therapeutic viruses","volume":"62","author":"Fisher","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2015.09.014_b0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.mt.6300306","article-title":"Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies","volume":"16","author":"Wortmann","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2015.09.014_b0085","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/10611860701501014","article-title":"Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy","volume":"15","author":"Fisher","year":"2007","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actbio.2015.09.014_b0090","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1089\/hum.2009.028","article-title":"Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus","volume":"20","author":"Doronin","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2015.09.014_b0095","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/mt.2011.112","article-title":"Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapy","volume":"19","author":"Yao","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2015.09.014_b0100","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.biomaterials.2009.11.043","article-title":"The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2015.09.014_b0105","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1016\/j.biomaterials.2011.08.066","article-title":"Bioreducible polymer-conjugated oncolytic adenovirus for hepatoma-specific therapy via systemic administration","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2015.09.014_b0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/mp900151k","article-title":"Anionic liposomes increase the efficiency of adenovirus-mediated gene transfer to coxsackie-adenovirus receptor deficient cells","volume":"7","author":"Zhong","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2015.09.014_b0115","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1016\/j.biomaterials.2011.03.084","article-title":"Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2015.09.014_b0120","doi-asserted-by":"crossref","first-page":"781","DOI":"10.5483\/BMBRep.2010.43.12.781","article-title":"Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity","volume":"43","author":"Kang","year":"2010","journal-title":"BMB Rep."},{"key":"10.1016\/j.actbio.2015.09.014_b0125","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.biomaterials.2011.11.020","article-title":"Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials","volume":"33","author":"Kim","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2015.09.014_b0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymthe.2004.09.015","article-title":"Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses","volume":"11","author":"Mok","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2015.09.014_b0135","doi-asserted-by":"crossref","first-page":"13062","DOI":"10.1128\/JVI.77.24.13062-13072.2003","article-title":"Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation","volume":"77","author":"Koizumi","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.actbio.2015.09.014_b0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1525-0016(03)00139-4","article-title":"Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates","volume":"8","author":"Lanciotti","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2015.09.014_b0145","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1089\/104303403769211637","article-title":"Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner","volume":"14","author":"Kim","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2015.09.014_b0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2013.03.030","article-title":"Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy","volume":"169","author":"Kwon","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2015.09.014_b0155","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/bm300985r","article-title":"PH-Sensitive polymeric micelle-based pH probe for detecting and imaging acidic biological environments","volume":"13","author":"Lee","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2015.09.014_b0160","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1016\/j.biomaterials.2014.03.060","article-title":"Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression","volume":"35","author":"Lee","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2015.09.014_b0165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0168-3659(03)00205-0","article-title":"Poly(l-histidine)-PEG block copolymer micelles and pH-induced destabilization","volume":"90","author":"Lee","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2015.09.014_b0170","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/mabi.200500121","article-title":"PH-induced micelle formation of poly(histidine-co-phenylalanine)-block-poly(ethylene glycol) in aqueous media","volume":"5","author":"Kim","year":"2005","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.actbio.2015.09.014_b0175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2007.11.014","article-title":"Physicochemical characteristics of pH-sensitive poly(l-histidine)-b-poly(ethylene glycol)\/poly(l-lactide)-b-poly(ethylene glycol) mixed micelles","volume":"126","author":"Yin","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2015.09.014_b0180","doi-asserted-by":"crossref","first-page":"10821","DOI":"10.1128\/JVI.01428-12","article-title":"Spatiotemporal dynamics of adenovirus membrane rupture and endosomal escape","volume":"86","author":"Maier","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.actbio.2015.09.014_b0185","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymthe.2005.03.001","article-title":"Increased hepatic transduction with reduced systemic dissemination and proinflammatory cytokines following hydrodynamic injection of helper-dependent adenoviral vectors","volume":"12","author":"Brunetti-Pierri","year":"2005","journal-title":"Mol. Ther."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706115301082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706115301082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:44:26Z","timestamp":1761669866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706115301082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":37,"alternative-id":["S1742706115301082"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2015.09.014","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced anti-tumor efficacy and safety profile of tumor microenvironment-responsive oncolytic adenovirus nanocomplex by systemic administration","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2015.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}